



Moon CommentaryDr Sundt. And I agree with you. I didn’t mean to take a shot at
you for the 4% rate in the primary cases or the 8% in the redos. The
real question, though, is, would the stroke rate have been less if
they had been perfused from the ascending aorta rather than
from the groin? But I appreciate that it is difficult to answer that
question.
Dr Bolman. Well, they are perfused antegrade. The patients
receive percutaneous venous but central aortic cannulation.
Dr Sundt. It was only percutaneous femoral?
Dr ElBardissi. They are cannulated centrally and perfused cen-
trally except in reoperations, in which case they are perfused pe-
ripherally through the femoral artery or they are perfused
through the axillary artery, but in all primary operations they are
perfused through the aorta.
Dr Sundt. I am sorry I misunderstood. Thank you very much.
Dr Hillel Laks (Los Angeles, Calif). One of the factors that was
not discussed in the article on robotic mitral valve surgery that we
just heard or in this article on MiniAVRwas the effects of these ap-
proaches on the brain, on neurocognitive function. One of the great
concerns that many surgeons have is the issue of de-airing of the
heart at the end of these procedures, which has been shown by
transcranial Doppler to shower the brain with microemboli, andCOMMEN
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The Journal of Thoracic and Cathe literature is replete with studies retrospectively that have shown
30% of patients having some neurocognitive dysfunctions. Do you
know of any studies that have been done to compare these ap-
proaches, and particularly this one, in terms of neurocognitive func-
tion recovery, which is particularly pertinent to the old age group?
Dr ElBardissi.As far as neurocognitive function, if we are talk-
ing about these transient, diffuse neurocognitive dysfunction epi-
sodes, I don’t know of any studies. If we are talking about acute
events such as strokes or transient ischemic attacks, I can tell
you that our institution did a retrospective study that was published
in the Annals of Surgery and found no significant difference be-
tween the minimally invasive approach and the open approach
as far as those acute events are concerned.
Dr Laks. I would like to emphasize that the incidence of clin-
ically apparent strokes underrepresents diffuse brain injury that
can result in neurocognitive dysfunction and that can be present
as long as 6 months after surgery, and it is thought that many of
those may be permanent. I think before we declare that these
approaches are superior or equal, a randomized or equivalent
type of study needs to be done looking at neurocognitive function
both for robotic mitral valve surgery and for other minimally
invasive approaches.TARYPredictive value of surgical scoring systems in determining operative
risk for octogenarians undergoing aortic valve replacementMarc R. Moon, MDIn a retrospective, single-center study, ElBardissi and asso-
ciates1 report the results of isolated aortic valve replacement
(AVR) in 249 octogenarians from 1996 to 2009, during which
time they performed a minimally invasive approach in almost
all patients. This study does not compare the minimally
invasive approach with the traditional AVR via median ster-
notomy, so any conclusions as to the impact of a particular
surgical approach would not be reasonable. Therefore, I will
make no reference to the specific surgical technique, but referonly to AVR in general. The authors’ specific aims included
the following: (1) demonstrate that AVR can be performed
safely in high-risk patients; (2) document long-term survival
as a benchmark for future studies; and (3) assess the reliability
of two current risk-prediction models, The Society of
Thoracic Surgeons Predicted Risk of Mortality (STS-
PROM)andmodifiedEuropeanSystemforCardiacOperative
Risk Evaluation (EuroSCORE) algorithms,2,3 hypothesizing
that these current risk-prediction models ‘‘overestimate risk
in appropriately chosen and optimized patients.’’ Although
the authors were successful in addressing specific aims 1
and 2, they may have fallen short in their assessment of the
STS-PROM and EuroSCORE risk score algorithms.SPECIFIC AIM 1
The authors report operative mortality of 3% 2% (95%
confidence limit) for octogenarians undergoing AVR during




Commentary Moonhours, and major complications included stroke in 4%,
pneumonia in 1%, and renal failure requiring dialysis in
1%. These operative results are outstanding, especially
considering that this group had a median predicted surgical
risk of 10.5% and 11% using STS-PROM and EuroSCORE,
respectively. Thus, the authors’ first hypothesis was
true—AVR can be performed safely in high-risk patients.
SPECIFIC AIM 2
The authors report long-term survival after AVR at 1, 5,
and 10 years to be 91%, 77%, and 56%, respectively (no
measure of variability was provided). Compared with
2002 US Census data, survival was similar to that of an
age-matched, gender-matched population (P ¼ .88), both
of which were substantially better than reported survival
of octogenarians with aortic stenosis who had been denied
surgery (52% 1-year and 22% 5-year survivals).4 Thus,
the authors successfully demonstrated that AVR in octoge-
narians can restore normal life expectancy, a benchmark
against which future studies can be compared.
SPECIFIC AIM 3
The authors report that although the STS score and
EuroSCORE were well correlated (r ¼ 0.40, P< .0001),
the c-index (area under the receiver operator curve, which
quantifies discriminatory ability) approached random
chance (c-index ¼ 0.5) rather than perfect discrimination
(1.0) for both algorithms in this cohort of patients, 0.67
(P ¼ .18) for STS-PROM and 0.53 (P ¼ .74) for Euro-
SCORE. In addition, the Hosmer–Lemeshow statistic,
which evaluates model calibration, confirmed that neither
scoring system effectively predicted mortality in this
selected patient cohort (P ¼ .38 for STS-PROM and P ¼
.50 for EuroSCORE). From these data, the authors
concluded that ‘‘current risk-predictionmodels are not repre-
sentative of the outcomes after cardiac surgery.’’ Caution
needs to be expressed when evaluating the validity of this
conclusion. The conclusion that the STS and European data-
bases do not accurately predict operative risk can only be
made after an adequately powered, randomized study, neither
of which was present in the current retrospective analysis.
Population-based studies, although helpful in assessing
the global community, cannot reliably predict the response
of individual subjects or selected cohorts. Although one
center may have an operative risk that is higher or lower
than the model norms, the STS score and EuroSCORE do
not overestimate risk for the entire study population. In
fact, if the risk factor algorithms were applied to the entire
database from which they were developed, their c-index
would likely approach unity or perfect discrimination.
According to the 2009 STS Executive Summary, the aver-
age center performs 301 cardiac surgery procedures, of
which only 45 are AVRs5; surely these numbers pale
in comparison with those reported from the Brigham.336 The Journal of Thoracic and Cardiovascular SurgAlthough 12 surgeons contributed patients to this study,
the majority of the operations were performed by the senior
surgeon, whom many consider to be one of the elite sur-
geons in the world during the past quarter century. I would
speculate that the senior surgeon’s results with coronary by-
pass grafting, mitral valve repair, and other cardiac proce-
dures may also outperform the STS database, but this, in
and of itself, does not invalidate the applicability of STS
predicted risk to the ‘‘everyday’’ surgeon. Brown,6 Dewey,7
Wendt,8 and their associates also identified discrepancies
between the STS score and operative results at their individ-
ual centers, albeit not quite as striking as the current report.
Regardless, mathematical principle dictates that for each
center like the Brigham that outperforms predictive risk
within the STS or European database, there is a correspond-
ing center (or centers) that underperforms predictive risk.
Risk-prediction models simply cannot overestimate the
risk of surgery in the population in which they were devel-
oped, assuming, of course, consistent, standardized defini-
tions and quality data entry.9
One of the secondary goals of the Brigham study was to
evaluate outcome in octogenarians who might otherwise be
considered candidates for transcatheter aortic valve implan-
tation (TAVI). This is reflected in the title, describing the co-
hort as ‘‘TAVI candidates.’’ However, according to current
criteria for inclusion in the surgical arm of most randomized
studies, a predicted operative risk of 8% to 10% is required
for TAVI consideration, which would exclude over 25% of
the patients included in this analysis. Although the authors
did not report operative mortality for each predictive risk
quartile, I suspect that mortality rates were quite low, even
among the highest risk subset (17% and above), such that
at the Brigham, very few patients, potentially only those
at extreme risk, should ever be offered TAVI. In contrast,
at centers whose operative mortality rates for AVR exceed
STS norms, even patients with low predicted risk (4%–
6%) may best be served with a percutaneous approach
(based on the results of pending randomized studies, of
course). This type of discussion could easilymeld into a shift
toward Pay for Performance and Centers of Excellence, but
the reality remains that Centers of Excellence like the Brig-
ham do not have the capacity to perform every AVR in the
United States, and patient management decisions are going
to continue to be individualized at the local level.
The beauty of the STS-PROMmodel is that it falls prey to
very little selection bias (ie, elective participation, quality of
follow-up data) and generates a starting point from which
a surgeon can predict surgical risk for John Q. Public,
with adjustments based on local modifiers. Only with cau-
tion can we extrapolate the findings of a single-center study
to the general population inasmuch as published studies are
generally lopsided toward success. Although the Brigham
group may be eager to publish their outstanding results in




Moon Commentarybe reticent to publicize their results. Results reported by the
world’s experts can be something for which to strive, but
cannot reasonably be extrapolated to ‘‘Anytown, USA.’’
The STS score and EuroSCORE remain outstanding
tools for preoperative patient counseling and quality im-
provement initiatives for individual centers and surgeons,
so long as those using the algorithms understand the essen-
tial need to consider local modifiers that may affect
outcomes when applying these data to individual patients
or selected patient cohorts. ElBardissi and coauthors1
express concern that ‘‘current scoring systems alone should
not be used’’ to predict survival and that ‘‘current models
for determining inoperability are unreliable,. and should
not unilaterally determine clinical practices,’’ but this is
nothing new. Such has never been the intent of
population-based risk modeling protocols, and the STS
clearly states, ‘‘These risks are solely statistical estimates,
they should be supplemented by the professional judgment
of the patients’ healthcare provider, particularly their car-
diac surgeon.’’10 Furthermore, there are surely patient fac-
tors that can affect operative risk that are difficult to
characterize and or quantify (frailty, porcelain aorta, etc).
The ‘‘eyeball test’’ can go a long way to help a surgeon,
who understands his own limitations and those of his insti-
tution, predict a suboptimal outcome and identify patients
whose operative risk may be substantially higher than stan-
dard algorithms predict.
In summary, ElBardissi and colleagues1 are to be com-
mended for their excellent results in this high-risk, elderly
group undergoing AVR, but until randomized studies de-
bunk the results from STS and European database-
generated analyses, these algorithms will remain criticalThe Journal of Thoracic and Cafor the preoperative assessment and postoperative evalua-
tion of cardiac surgical patients and will best represent the
expected outcomes for the ‘‘everyday surgeon,’’ more so
than data that emanate from individual, retrospective,
single-center studies.
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